Animal models of neuroimmune interactions in inflammatory diseases

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 13-20

  Jafarian Tehrani, Mehrnaz ^a   Sternberg, Esther M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CYTOKINE; CYTOKINE RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MIFEPRISTONE; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; ENCEPHALITIS; GENE EXPRESSION; GENETIC LINKAGE; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0033392090     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00207-6     Document Type: Article

References (76)

1. Akwa Y., Hassett D.E., Eloranta M.L., Sandberg K., Masliah E., Powell H., Whitton J.L., Bloom F.E., Campbell I.L. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161:1998;5016-5026.
2. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., Trent J.M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA. 95:1998;9979-9984.
3. Bellinger F.P., Madamba S., Siggins G.R. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:1993;227-234.
4. Besedovsky H.O., del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 17:1996;64-102.
5. Bluthe, R.M., Jafarian-Tehrani, M., Michaud, B., Haour, F., Dantzer, R., Homo-Delarche, F. (1999). Increased sensitivity of prediabetic NOD mouse to the behavioral effects of IL-1 receptor defect in autoimmune NZB mouse brain. Brain, Behav. and Autoimmunity (in press).
6. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 240:1988;321-324.
7. Brenneman D.E., Page S.W., Schultzberg M., Thomas F.S., Zelazowski P., Burnet P., Avidor R., Sternberg E.M. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J. Pharmacol. Exp. Ther. 266:1993;1029-1035.
8. Brenneman D.E., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
9. Campbell I.L. Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Res. Brain Res. Rev. 26:1998;327-336.
10. Campbell I.L. Structural and functional impact of the transgenic expression of cytokines in the CNS. Ann. N.Y. Acad. Sci. 840:1998;83-96.
11. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci USA. 90:1993;10061-10065.
12. Diana A., Van Dam A.M., Winblad B., Schultzberg M. Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neuroscience. 89:1999;137-147.
13. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nat. Genet. 21:1999;10-14.
14. Edwards C.K.d., Yunger L.M., Lorence R.M., Dantzer R., Kelley K.W. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA. 88:1991;2274-2277.
15. Fantuzzi G., Dinarello C.A. The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukoc. Biol. 59:1996;489-493.
16. Grazia de Simoni M., Imeri L., De Matteo W., Perego C., Simard S., Terrazzino S. Sleep regulation: interactions among cytokines and classical neurotransmitters [published erratum appears in Adv Neuroimmunol 1996;6(1):117]. Adv. Neuroimmunol. 5:1995;189-200.
17. Green P.G., Luo J., Heller P.H., Levine J.D. Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience. 55:1993;1037-1043.
18. Green P.G., Miao F.J., Strausbaugh H., Heller P., Janig W., Levine J.D. Endocrine and vagal controls of sympathetically dependent neurogenic inflammation. Ann. N.Y. Acad. Sci. 840:1998;282-288.
19. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L.d., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
20. Haour F., Jafarian-Tehrani M., Gabellec M.M., Crumeyrolle-Arias M., Hu Y., Wick G., Ternynck T. Interleukin-1 receptor defect in autoimmune NZB mouse brain. Ann. N.Y. Acad. Sci. 840:1998;755-761.
21. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1:1991;97-105.
22. Hu Y., Dietrich H., Herold M., Heinrich P.C., Wick G. Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102:1993;232-241.
23. Jafarian-Tehrani M., Gabellec M.M., Adyel F.Z., Simon D., Griffais R., Ternynck T., Haour F. Interleukin-1 receptor deficiency in the hippocampal formation of (NZB×NZW)F2 mice: genetic and molecular studies relating to autoimmunity. J. Neuroimmunol. 84:1998;30-39.
24. Jafarian-Tehrani M., Hu Y., Marquette C., Dietrich H., Haour F., Wick G. Interleukin-1 receptor deficiency in brains from NZB and (NZB/NZW)F1 autoimmune mice. J. Neuroimmunol. 53:1994;91-99.
25. Katsuki H., Nakai S., Hirai Y., Akaji K., Kiso Y., Satoh M. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181:1990;323-326.
26. Kluger M.J. Fever: role of pyrogens and cryogens. Physiol. Rev. 71:1991;93-127.
27. Kono D.H., Burlingame R.W., Owens D.G., Kuramochi A., Balderas R.S., Balomenos D., Theofilopoulos A.N. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci USA. 91:1994;10168-10172.
28. Kozak W., Kluger M.J., Soszynski D., Conn C.A., Rudolph K., Leon L.R., Zheng H. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann. N.Y. Acad. Sci. 856:1998;33-47.
29. Krueger J.M., Fang J., Taishi P., Chen Z., Kushikata T., Gardi J. Sleep. A physiologic role for IL-1 beta and TNF-alpha. Ann. N.Y. Acad. Sci. 856:1998;148-159.
30. Krueger J.M., Walter J., Dinarello C.A., Wolff S.M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 246:1984;R994-R999.
31. Lechner O., Hu Y., Jafarian-Tehrani M., Dietrich H., Schwarz S., Herold M., Haour F., Wick G. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain. Behav. Immun. 10:1996;337-350.
32. Levine J.D., Dardick S.J., Roizen M.F., Helms C., Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. Neurosci. 6:1986;3423-3429.
33. Licinio J., Wong M.L. Pathways and mechanisms for cytokine signaling of the central nervous system. J. Clin. Invest. 100:1997;2941-2947.
34. Listwak S., Barrientos R.M., Koike G., Ghosh S., Gomez M., Misiewicz B., Sternberg E.M. Identification of a novel inflammation-protective locus in the Fischer rat. Mamm. Genome. 10:1999;362-365.
35. Lorentzen J.C., Glaser A., Jacobsson L., Galli J., Fakhrai-rad H., Klareskog L., Luthman H. Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc. Natl. Acad. Sci USA. 95:1998;6383-6387.
36. Luheshi G., Rothwell N. Cytokines and fever. Int. Arch. Allergy Immunol. 109:1996;301-307.
37. Maier S.F., Goehler L.E., Fleshner M., Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann. N.Y. Acad. Sci. 840:1998;289-300.
38. Mason D., MacPhee I., Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology. 70:1990;1-5.
39. McCann, S.M., Sternberg, E.M., Lipton, J.M., Chrousos, G.P., Gold, P.W., Smith, C.C. (1998). Neuroimmunomodulation: Molecular Aspects, Integrative Systems, and Clinical Advances. Proceedings of the 3rd Congress of the International Society of NeuroImmunoModulation (ISNIM). Bethesda, MD, USA. November 13-15, 1996. Ann. N.Y. Acad. Sci. 840, 1-866.
40. Misiewicz B., Poltorak M., Raybourne R.B., Gomez M., Listwak S., Sternberg E.M. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation. Exp. Neurol. 146:1997;305-314.
41. Mohan C., Morel L., Yang P., Watanabe H., Croker B., Gilkeson G., Wakeland E.K. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103:1999;1685-1695.
42. Morel L., Mohan C., Yu Y., Schiffenbauer J., Rudofsky U.H., Tian N., Longmate J.A., Wakeland E.K. Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm. Genome. 10:1999;176-181.
43. Pasinelli P., Borchelt D.R., Houseweart M.K., Cleveland D.W., Brown R.H. Jr. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase [published erratum appears in Proc. Natl. Acad. Sci USA 1999 Mar 16;96(6):3330]. Proc. Natl. Acad. Sci USA. 95:1998;15763-15768.
44. Pezzone M.A., Dohanics J., Rabin B.S. Effects of footshock stress upon spleen and peripheral blood lymphocyte mitogenic responses in rats with lesions of the paraventricular nuclei. J. Neuroimmunol. 53:1994;39-46.
45. Plata-Salaman C.R. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15:1991;185-215.
46. Powell H.C., Garrett R.S., Brett F.M., Chiang C.S., Chen E., Masliah E., Campbell I.L. Response of glia, mast cells and the blood brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination. Brain Pathol. 9:1999;219-235.
47. Raber J., O'Shea R.D., Bloom F.E., Campbell I.L. Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice. J. Neurosci. 17:1997;9473-9480.
48. Raber J., Sorg O., Horn T.F., Yu N., Koob G.F., Campbell I.L., Bloom F.E. Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res. Brain Res. Rev. 26:1998;320-326.
49. Remmers E.F., Longman R.E., Du Y., O'Hare A., Cannon G.W., Griffiths M.M., Wilder R.L. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat. Genet. 14:1996;82-85.
50. Roth M.P., Viratelle C., Dolbois L., Delverdier M., Borot N., Pelletier L., Druet P., Clanet M., Coppin H. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J. Immunol. 162:1999;1917-1922.
51. Rothwell N., Allan S., Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:1997;2648-2652.
52. Rothwell N.J., Luheshi G., Toulmond S. Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol. Ther. 69:1996;85-95.
53. Rothwell N.J., Strijbos P.J. Cytokines in neurodegeneration and repair. Int. J. Dev. Neurosci. 13:1995;179-185.
54. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci USA. 95:1998;7778-7783.
55. Sei Y., Vitkovic L., Yokoyama M.M. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodulation. 2:1995;121-133.
56. Sheng J.G., Mrak R.E., Griffin W.S. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21:1995;290-301.
57. Stalder A.K., Carson M.J., Pagenstecher A., Asensio V.C., Kincaid C., Benedict M., Powell H.C., Masliah E., Campbell I.L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 153:1998;767-783.
58. Stanley L.C., Mrak R.E., Woody R.C., Perrot L.J., Zhang S., Marshak D.R., Nelson S.J., Griffin W.S. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53:1994;231-238.
59. Steffensen S.C., Campbell I.L., Henriksen S.J. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652:1994;149-153.
60. Sternberg E.M. Neural-immune interactions in health and disease. J. Clin. Invest. 100:1997;2641-2647.
61. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci USA. 86:1989;2374-2378.
62. Sternberg E.M., Young W.S.d., Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., Wilder R.L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci USA. 86:1989;4771-4775.
63. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:1995;3468-3474.
64. Taupin V., Renno T., Bourbonniere L., Peterson A.C., Rodriguez M., Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur. J. Immunol. 27:1997;905-913.
65. Toth L.A. Strain differences in the somnogenic effects of interferon inducers in mice. J. Interferon Cytokine Res. 16:1996;1065-1072.
66. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79:1999;1-71.
67. Vasilakos J., Shivers B. Watch for ICE in neurodegeneration. Mol. Psychiatry. 1:1996;72-76.
68. Vitkovic L. Neuropathogenesis of HIV-1 infection: interactions between interleukin-1 and transforming growth factor-beta 1. Mol. Psychiatry. 2:1997;111-112.
69. Vitkovic L., Tardieu M. Neuropathogenesis of HIV-1 infection. Outstanding questions. CR Acad. Sci. III. 321:1998;1015-1021.
70. Weller R.O., Engelhardt B., Phillips M.J. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 6:1996;275-288.
71. Wick G., Hu Y., Schwarz S., Kroemer G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. 14:1993;539-563.
72. Wick G., Sgonc R., Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann. N.Y. Acad. Sci. 840:1998;591-598.
73. Wick G., Sundick R.S., Albini B. A review: The obese strain (OS) of chickens: an animal model with spontaneous autoimmune thyroiditis. Clin. Immunol. Immunopathol. 3:1974;272-300.
74. Wilder R.L., Calandra G.B., Garvin A.J., Wright K.D., Hansen C.T. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum. 25:1982;1064-1072.
75. Williams K.C., Ulvestad E., Hickey W.F. Immunology of multiple sclerosis. Clin. Neurosci. 2:1994;229-245.
76. Yoshioka M., Itoh Y., Mori K., Ueno K., Matsumoto M., Togashi H. Effects of an interleukin-1beta analogue [Lys-D-Pro-Thr], on incomplete cerebral ischemia-induced inhibition of long-term potentiation in rat hippocampal neurons in vivo. Neurosci. Lett. 261:1999;171-174.